Erik Hansen

Ivantis, Inc. develops technology to treat ophthalmic diseases. The firm develops solutions for glaucoma and offers an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. It provides its solutions for use in clinical trials to ophthalmology specialists. Ivantis was founded in 2007 and is headquartered in Irvine, CA.

Magnetica Ltd. is a biomedical engineering and technology company. The firm's activities include designing, developing and commercializing superconducting and non-superconducting magnet systems and magnet sub systems used in magnetic resonance imaging scanners for human diagnostic imaging. The company was founded in 2005 and is headquartered Eagle Farm, Australia.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

GBS Venture Partners Pty Ltd (GBS Venture Partners) is a venture capital firm founded in 1996 by Helen Brigitte Smith and Geoff E.D Brooke. The firm is headquartered in Melbourne.

Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia.

The European Hydrogen Association (EHA) is an organization that promotes the use of hydrogen as a clean energy source. The organization is based in Brussels, Belgium and is a network partner of the UNFCC Climate Technology Centre and Network. The EHA provides information and resources to its members, including updates on hydrogen infrastructure development and trade, tools for small projects, and educational courses. The EHA recently facilitated the first CTCN technical assistance request of the Brazilian government on hydrogen. The website requires the use of cookies to login and save preferences.

Implicit Bioscience Ltd. operates as a clinical-stage immunotherapy drug development company. It develops drugs that modulate the host immune response to disease. The firm develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents. The company was founded by Garry Llewellyn Redlich, Peter Ronald Andrews and Ian Hector Frazer and is headquartered in Woolloongabba, Australia.

GreenSync Pty Ltd. operates as a global energy technology company. It offers portfolioVPM for retailers, portfolioCM for networks, peakresponse for business, and microEM for operators. The company was founded by Phil Blythe in 2010 and is headquartered in Melbourne, Australia.

Omni Tanker Pty Ltd. specializes in lightweight bulk liquid transport and chemical tankers. The company is based in Australia, specifically in an undisclosed location. The Australian company's flagship product, the Omni Tanker, offers greater payloads and versatility compared to traditional tankers. The company was founded in 2006 by Daniel Rodgers, who has been the CEO since its inception.